---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-066396"
form_type: "8-K"
ticker: "GERN"
cik: "0000886744"
company_name: "GERON CORP"
filed_at: "2023-11-28T23:59:59+00:00"
generated_at: "2026-06-07T21:16:26.768401+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Geron appoints Gaurav Aggarwal, M.D. to its Board of Directors

## Summary
- Dr. Aggarwal appointed as Class III director effective Nov. 26, 2023; term expires at 2026 annual meeting.
- Board determined Aggarwal independent under Nasdaq rules; he brings 20+ years life sciences investing experience.
- Received initial option for 200,000 shares at $1.97/share, vesting in three equal annual installments.
- Eligible for annual cash retainer of $42,500 and annual option grants of 125,000 shares starting in 2024.

## SEC filing metadata
- accession: 0000950170-23-066396
- form_type: 8-K
- ticker: GERN
- cik: 0000886744
- company_name: GERON CORP
- filed_at: 2023-11-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/886744/000095017023066396/0000950170-23-066396-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/886744/000095017023066396/gern-20231126.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-066396
- JSON: https://secwatch.observer/filing/0000950170-23-066396.json
- Plain text: https://secwatch.observer/filing/0000950170-23-066396.txt

## Key facts
- Executive change
  Gaurav Aggarwal was appointed as Director at GERON CORP.
  - Action: appointed
  - Role: Director
  source text: appointed Gaurav Aggarwal, M.D. to the Board, effective immediately, as a Class III Board member with a term expiring at the Company’s 2026 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/886744/000095017023066396/0000950170-23-066396-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.